2-chloro-5H,7H,8H-pyrano[4,3-b]pyridine-3-carbonitrile, 95.0%, 1g

4-Cyclopropyl-1H-pyrazole, 95.0%, 250mg

TENAPANOR, 95%, 50mg

4'-Methoxyphenyl acetylene, 98.0%, 100g

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide, 98.0%, 25g

4-Hydroxy-5-methoxy-2-nitro-benzoic acid methyl ester, 90.0%, 10g

4-Hydroxybenzoic acid, min. 98%, for synthesis, 5 g, glass packaging

2,4-Difluoro-1,3,5-trimethylbenzene, 95.0%, 10g

N-methyl-N-(4-thien-2-ylbenzyl)amine, 100mg

3-Bromo-1-ethyl-1H-pyrazole, 97.0%, 1g

2,2-difluoro-2-triphenylphosphaniumylacetate, 97%, 100g

3-((TERT-BUTOXYCARBONYL)AMINO)PIPERIDINE-3-CARBOXYLIC ACID, 95.0%, 5g

Azepane-2-carboxylic acid, 95.0%, 5g